Resumo:
En
|
Texto:
En
|
PDF:
En
Abstract Objectives: Allergic diseases and Meniere’s disease found to have a possible link in observational study. However, the potential causal relationship between the two is unclear. Therefore, we aimed to explore the causal relationship between allergic diseases and Meniere’s disease using a new data analysis technique called bidirectional Mendelian randomization study. Method: Summary-level statistics for Meniere’s disease and three allergic diseases (asthma, allergic rhinitis, eczema/dermatitis) were obtained from large-scale genome-wide association studies. The inverse variance weighted method was used as the primary measure, supplemented by MR-Egger regression and the weighted median method. To ensure the reliability of the conclusions, Cochran’s Q, MR-Egger intercept, MR-PRESSO test, leave-one-out test, and MR Steiger test were used. Results: Inverse-variance weighted method showed asthma (p = 0.008, OR = 3.908, 95% CI 1.424 − 10.724, adjust p = 0.024), allergic rhinitis (p = 0.026, OR = 24.714, 95% CI 1.479 − 412.827, adjust_p = 0.026) and eczema/dermatitis (p = 0.019, OR = 3725.954, 95% CI 3.795 to 3,658,399.580, adjust_p = 0.029) all had a significant effect on Meniere’s disease. Reverse Mendelian randomization studies have shown that Meniere’s disease does not increase the risk of three allergic diseases. Sensitivity analysis showed no horizontal pleiotropy and heterogeneity for each trait. Conclusion: Our Mendelian randomization analysis supports a positive causal relationship between three allergic diseases (asthma, allergic rhinitis, eczema/dermatitis) and Meniere’s disease. This suggests that physicians should pay more attention to the Meniere’s patient’s allergy history and consider allergy avoidance as part of their treatment plan. Level of evidence: Mendelian Randomized (MR) studies are second only to randomized controlled trials in terms of the level of evidence. Objectives Menieres Meniere s study However unclear Therefore Method Summarylevel Summary asthma, (asthma eczemadermatitis eczema dermatitis largescale large scale genomewide genome wide measure MREgger Egger conclusions Cochrans Cochran Q intercept MRPRESSO PRESSO leaveoneout leave one out Results Inversevariance Inverse 0008 0 008 0.008 3908 3 908 3.908 95 1424 1 424 1.42 10724 10 724 10.724 0.024, 0024 0.024 , 024 0.024) 0026 026 0.026 24714 24 714 24.714 1479 479 1.47 412827 412 827 412.827 adjustp 0019 019 0.019 3725954 3725 954 3725.954 3795 795 3.79 3658399580 658 399 580 3,658,399.580 0.029 0029 029 trait Conclusion patients patient plan evidence (MR 000 00 0.00 390 90 3.90 9 142 42 1.4 1072 72 10.72 002 0.02 02 2471 2 71 24.71 147 47 41282 41 82 412.82 001 01 0.01 372595 372 3725.95 379 79 3.7 365839958 65 39 58 3,658,399.58 0.0 3.9 14 4 1. 107 7 10.7 247 24.7 4128 8 412.8 37259 37 3725.9 3. 36583995 6 5 3,658,399.5 0. 10. 24. 412. 3725. 3658399 3,658,399. 365839 3,658,399 36583 3,658,39 3658 3,658,3 365 3,658, 36 3,658 3,65 3,6 3,